AM
Amit Mehta
About Amit Mehta
Data last updated:
Amit Mehta is a Director at Sri Guru Enterprises Pharma Private Limited (since 2022). The company operates in Pharma. Sri Guru Enterprises Pharma Private Limited reported revenue of ₹9.73 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sri Guru Enterprises Pharma Private Limited U51100TN2020PTC134500 | Director | 19 Mar 2022 | 2020 | ₹9.73 Cr (FY 2025) | Active |
Board colleagues of Amit Mehta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jitendra Kothari | 09541167 | Sri Guru Enterprises Pharma Private Limited | Director |
| Mukesh Sajjanraj Bhandari Bhandari | 09541138 | Sri Guru Enterprises Pharma Private Limited | Director |
| Ranjeet Kumar Kothari | 09541175 | Sri Guru Enterprises Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amit Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amit Mehta
Amit Mehta currently holds 1 directorship: Sri Guru Enterprises Pharma Private Limited (Director, since 19 Mar 2022, revenue ₹9.73 Cr (FY 2025)).
Amit Mehta was first appointed on 19 Mar 2022 as Director at Sri Guru Enterprises Pharma Private Limited.
The current boards of Amit Mehta's companies include Jitendra Kothari (Sri Guru Enterprises Pharma Private Limited), Mukesh Sajjanraj Bhandari Bhandari (Sri Guru Enterprises Pharma Private Limited), Ranjeet Kumar Kothari (Sri Guru Enterprises Pharma Private Limited).